CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
Open Access
- 8 July 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (32) , 51525-51534
Abstract
CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinomaKeywords
This publication has 27 references indexed in Scilit:
- High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinomaUrologic Oncology: Seminars and Original Investigations, 2016
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015
- Tumor-Associated Macrophages: From Mechanisms to TherapyImmunity, 2014
- Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary ReviewEuropean Urology, 2011
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical ApplicabilityEuropean Urology, 2009
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasisNature, 2009
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- Chemokines and cancerInternational Journal of Cancer, 2006